81 related articles for article (PubMed ID: 21683447)
1. Electrostatic exploration of the C3d-FH4 interaction using a computational alanine scan.
El-Assaad AM; Kieslich CA; Gorham RD; Morikis D
Mol Immunol; 2011 Sep; 48(15-16):1844-50. PubMed ID: 21683447
[TBL] [Abstract][Full Text] [Related]
2. Immunophysical exploration of C3d-CR2(CCP1-2) interaction using molecular dynamics and electrostatics.
Zhang L; Mallik B; Morikis D
J Mol Biol; 2007 Jun; 369(2):567-83. PubMed ID: 17434528
[TBL] [Abstract][Full Text] [Related]
3. The effect of electrostatics on factor H function and related pathologies.
Kieslich CA; Vazquez H; Goodman GN; López de Victoria A; Morikis D
J Mol Graph Model; 2011 Aug; 29(8):1047-55. PubMed ID: 21605993
[TBL] [Abstract][Full Text] [Related]
4. Automated computational framework for the analysis of electrostatic similarities of proteins.
Kieslich CA; Morikis D; Yang J; Gunopulos D
Biotechnol Prog; 2011; 27(2):316-25. PubMed ID: 21485028
[TBL] [Abstract][Full Text] [Related]
5. Energetic evaluation of binding modes in the C3d and Factor H (CCP 19-20) complex.
E S Harrison R; Gorham RD; Morikis D
Protein Sci; 2015 May; 24(5):789-802. PubMed ID: 25628052
[TBL] [Abstract][Full Text] [Related]
6. Solvation effects in calculated electrostatic association free energies for the C3d-CR2 complex and comparison with experimental data.
Cheung AS; Kieslich CA; Yang J; Morikis D
Biopolymers; 2010 Jun; 93(6):509-19. PubMed ID: 20091675
[TBL] [Abstract][Full Text] [Related]
7. Mutational analyses reveal that the staphylococcal immune evasion molecule Sbi and complement receptor 2 (CR2) share overlapping contact residues on C3d: implications for the controversy regarding the CR2/C3d cocrystal structure.
Isenman DE; Leung E; Mackay JD; Bagby S; van den Elsen JM
J Immunol; 2010 Feb; 184(4):1946-55. PubMed ID: 20083651
[TBL] [Abstract][Full Text] [Related]
8. Electrostatic contributions drive the interaction between Staphylococcus aureus protein Efb-C and its complement target C3d.
Haspel N; Ricklin D; Geisbrecht BV; Kavraki LE; Lambris JD
Protein Sci; 2008 Nov; 17(11):1894-906. PubMed ID: 18687868
[TBL] [Abstract][Full Text] [Related]
9. The electrostatic nature of C3d-complement receptor 2 association.
Morikis D; Lambris JD
J Immunol; 2004 Jun; 172(12):7537-47. PubMed ID: 15187133
[TBL] [Abstract][Full Text] [Related]
10. A theoretical view of the C3d:CR2 binding controversy.
Mohan RR; Gorham RD; Morikis D
Mol Immunol; 2015 Mar; 64(1):112-22. PubMed ID: 25433434
[TBL] [Abstract][Full Text] [Related]
11. Mutational analysis of the complement receptor type 2 (CR2/CD21)-C3d interaction reveals a putative charged SCR1 binding site for C3d.
Hannan JP; Young KA; Guthridge JM; Asokan R; Szakonyi G; Chen XS; Holers VM
J Mol Biol; 2005 Feb; 346(3):845-58. PubMed ID: 15713467
[TBL] [Abstract][Full Text] [Related]
12. A structural basis for Staphylococcal complement subversion: X-ray structure of the complement-binding domain of Staphylococcus aureus protein Sbi in complex with ligand C3d.
Clark EA; Crennell S; Upadhyay A; Zozulya AV; Mackay JD; Svergun DI; Bagby S; van den Elsen JM
Mol Immunol; 2011 Jan; 48(4):452-62. PubMed ID: 21055811
[TBL] [Abstract][Full Text] [Related]
13. Cutting edge: members of the Staphylococcus aureus extracellular fibrinogen-binding protein family inhibit the interaction of C3d with complement receptor 2.
Ricklin D; Ricklin-Lichtsteiner SK; Markiewski MM; Geisbrecht BV; Lambris JD
J Immunol; 2008 Dec; 181(11):7463-7. PubMed ID: 19017934
[TBL] [Abstract][Full Text] [Related]
14. Solution structure of the complex between CR2 SCR 1-2 and C3d of human complement: an X-ray scattering and sedimentation modelling study.
Gilbert HE; Eaton JT; Hannan JP; Holers VM; Perkins SJ
J Mol Biol; 2005 Feb; 346(3):859-73. PubMed ID: 15713468
[TBL] [Abstract][Full Text] [Related]
15. Electrostatic Steering Accelerates C3d:CR2 Association.
Mohan RR; Huber GA; Morikis D
J Phys Chem B; 2016 Aug; 120(33):8416-23. PubMed ID: 27092816
[TBL] [Abstract][Full Text] [Related]
16. Characterization of Ehp, a secreted complement inhibitory protein from Staphylococcus aureus.
Hammel M; Sfyroera G; Pyrpassopoulos S; Ricklin D; Ramyar KX; Pop M; Jin Z; Lambris JD; Geisbrecht BV
J Biol Chem; 2007 Oct; 282(41):30051-61. PubMed ID: 17699522
[TBL] [Abstract][Full Text] [Related]
17. Binding of complement factor H to endothelial cells is mediated by the carboxy-terminal glycosaminoglycan binding site.
Jokiranta TS; Cheng ZZ; Seeberger H; Jòzsi M; Heinen S; Noris M; Remuzzi G; Ormsby R; Gordon DL; Meri S; Hellwage J; Zipfel PF
Am J Pathol; 2005 Oct; 167(4):1173-81. PubMed ID: 16192651
[TBL] [Abstract][Full Text] [Related]
18. Molecular dynamics simulations of wild type and mutants of human complement receptor 2 complexed with C3d.
Wan H; Hu JP; Tian XH; Chang S
Phys Chem Chem Phys; 2013 Jan; 15(4):1241-51. PubMed ID: 23229122
[TBL] [Abstract][Full Text] [Related]
19. A structural basis for complement inhibition by Staphylococcus aureus.
Hammel M; Sfyroera G; Ricklin D; Magotti P; Lambris JD; Geisbrecht BV
Nat Immunol; 2007 Apr; 8(4):430-7. PubMed ID: 17351618
[TBL] [Abstract][Full Text] [Related]
20. Molecular analysis of the interaction between staphylococcal virulence factor Sbi-IV and complement C3d.
Gorham RD; Rodriguez W; Morikis D
Biophys J; 2014 Mar; 106(5):1164-73. PubMed ID: 24606940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
